Global Auto Injectors market is expected to be more than USD 5 Billion by 2024
Access full Research: https://www.renub.com/auto-injectors-market-p.php Global auto-injectors market is expected to be more than USD 5 Billion by 2024. According to Renub Research analysis auto-injectors market will grow at double digit CAGR from 2018-2024 due to auto-injectors self-administration features which ultimately reduces the patients drug delivery cost. Increasing prevalence of anaphylaxis, new formulations and new drug delivery systems, rising self-medication practices, government reimbursements and growing demand for targeted drug delivery systems for treatments of chronic diseases are some other driving forces for this market. However, regulatory hurdles for approval of new devices and Mylan’s EpiPen prices in United States are some of the key challenges for the auto-injectors market. From November 2004 to May 2016, EpiPen price has grown close to 500 percent in United States. Auto-injector is a healthcare device used for fixed doses for the particular drug. It has two types of design prefilled and fillable. Auto-injectors design support user-friendly and are intended for self-administration by untrained people, by patients. In context of auto-injectors usability, it is available in re-usable and disposable form.
★
★
★
★
★
138 views • 12 slides
